Zoetis Inc (ZTS) Insider Heidi C. Chen Sells 37,453 Shares

Zoetis Inc (NYSE:ZTS) insider Heidi C. Chen sold 37,453 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $81.02, for a total value of $3,034,442.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Zoetis Inc (NYSE:ZTS) traded up $0.15 during trading hours on Wednesday, hitting $80.50. The stock had a trading volume of 3,403,364 shares, compared to its average volume of 3,110,459. The firm has a market cap of $38,689.28, a PE ratio of 46.00, a P/E/G ratio of 1.80 and a beta of 1.07. Zoetis Inc has a twelve month low of $52.25 and a twelve month high of $81.78. The company has a current ratio of 3.85, a quick ratio of 2.55 and a debt-to-equity ratio of 2.77.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 15th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.03. The business had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.40 billion. Zoetis had a return on equity of 65.96% and a net margin of 16.28%. The business’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.47 EPS. research analysts forecast that Zoetis Inc will post 3.02 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Stockholders of record on Friday, April 20th will be given a dividend of $0.126 per share. The ex-dividend date is Thursday, April 19th. This represents a $0.50 annualized dividend and a dividend yield of 0.63%. Zoetis’s dividend payout ratio is currently 28.57%.

Several equities research analysts have weighed in on ZTS shares. Barclays set a $77.00 price target on Zoetis and gave the stock a “hold” rating in a report on Saturday. Deutsche Bank upped their price target on Zoetis from $76.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, February 16th. Piper Jaffray Companies set a $88.00 price target on Zoetis and gave the stock a “buy” rating in a report on Friday, February 16th. Stifel Nicolaus restated a “buy” rating and set a $86.00 price target (up previously from $84.00) on shares of Zoetis in a report on Friday, February 16th. Finally, Bank of America upped their price target on Zoetis from $80.00 to $87.00 and gave the stock a “buy” rating in a report on Friday, February 16th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. Zoetis has an average rating of “Buy” and an average price target of $79.83.

Several large investors have recently added to or reduced their stakes in ZTS. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Zoetis during the 4th quarter worth about $108,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Zoetis during the 3rd quarter worth about $114,000. We Are One Seven LLC acquired a new position in shares of Zoetis during the 4th quarter worth about $120,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in shares of Zoetis by 251.9% during the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock worth $121,000 after acquiring an additional 1,360 shares in the last quarter. Finally, Premia Global Advisors LLC acquired a new position in shares of Zoetis during the 4th quarter worth about $122,000. 94.18% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this report on another site, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this report can be viewed at https://stocknewstimes.com/2018/02/21/zoetis-inc-zts-insider-heidi-c-chen-sells-37453-shares.html.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply